Lilly builds migraine arsenal with $960 million CoLucid buy
(Reuters) - Eli Lilly and Co will buy CoLucid Pharmaceuticals Inc for about $960 million, bringing back into its fold a promising therapy for migraine and positioning itself to capture a bigger... [Source]
Publication Date:Origin: reuters.com
Category: innovationNews
Topics: CoLucid, million, migraine, Lilly, bigger, capture, itself, positioning, therapy, promising, bringing, Pharmaceuticals, (Reuters), arsenal, builds
Source: http://feeds.reuters.com/~r/news/deals/~3/N3WJbTmksao/us-colucid-pharms-m-a-eli-lilly-idUSKBN1521O6